Meeting
2023 ASCO Annual Meeting
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: A cost consequence analysis using linked administrative data.
Authors
Alberto Hernando-Calvo
Princess Margaret Cancer Centre, Toronto, ON, Canada
Alberto Hernando-Calvo , Paul Nguyen , Philippe L. Bedard , Kelvin K. Chan , Ramy R. Saleh , Deirdre Weymann , Celeste Yu , Eitan Amir , Dean A Regier , Bishal Gyawali , Danielle Kain , Brooke Wilson , Craig Earle , Nicole Mittmann , Albiruni Ryan Abdul Razak , Trevor John Pugh , Christine Williams , Lillian L. Siu , Timothy P. Hanna
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Clinical Trial Registration Number
NCT02906943
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6650)
DOI
10.1200/JCO.2023.41.16_suppl.6650
Abstract #
6650
Poster Bd #
142
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
PRECISION 1: A phase 2, multicenter, open-label basket trial of nab-sirolimus for malignant solid tumors harboring pathogenic inactivating alterations in TSC1 and TSC2.
First Author: Gopa Iyer
Poster
2024 ASCO Gastrointestinal Cancers Symposium
PRECISION 1: A phase 2, multicenter, open-label basket trial of nab-sirolimus for malignant solid tumors harboring pathogenic inactivating alterations in TSC1 and TSC2.
First Author: Dustin A. Deming
Poster
2023 ASCO Annual Meeting
A phase II study of tinostamustine in patients (pts) with advanced solid tumours.
First Author: Anna Tinker
Poster
2023 ASCO Annual Meeting
End-of-life outcomes of patients with advanced cancer enrolled in palliative care.
First Author: Andrew Lynch